{"schema_version":"1","generated_at":"2026-11-02T21:16:24.102Z","data_as_of":null,"url":"https://www.findmykol.com/kol/henry-fung","json_url":"https://www.findmykol.com/kol/henry-fung/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"henry-fung","name":"Henry Fung","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Fox Chase Cancer Center","institution_url":"https://www.findmykol.com/institution/fox-chase-cancer-center","city":"Philadelphia","state":"PA","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1215997085","openalex":"A5112491875"},"summary":"Henry Fung is an Oncology physician affiliated with Fox Chase Cancer Center. OpenAlex indexes 234 publications with 7,369 citations (h-index 36); ClinicalTrials.gov lists 2 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":234,"cited_by_count":7369,"h_index":36,"latest_activity_year":2025,"source":"works"},"trials":{"count":2,"shown":2,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT02535247","title":"Study of MK-3475 Alone or in Combination With Copanlisib in Relapsed or Refractory NK and T-cell Non-Hodgkin Lymphoma","phase":"PHASE1/PHASE2","status":"TERMINATED","role":"Overall official","sponsor":"Fox Chase Cancer Center","source_url":"https://clinicaltrials.gov/study/NCT02535247","trial_url":"https://www.findmykol.com/trial/NCT02535247"},{"nct":"NCT00003827","title":"Combination Chemotherapy in Treating Patients With Myelodysplastic Syndrome","phase":"PHASE2","status":"UNKNOWN","role":"Overall official","sponsor":"ALZA","source_url":"https://clinicaltrials.gov/study/NCT00003827","trial_url":"https://www.findmykol.com/trial/NCT00003827"}],"source":"trials"},"payments":{"company_count":16,"program_years":{"first":2021,"last":null},"rows_total":34,"shown":3,"withheld":31,"rows":[{"payer":"Janssen Biotech, Inc.","program_year":2025,"amount_usd":96540.01,"payment_count":51,"source_url":"https://openpaymentsdata.cms.gov/search?query=1215997085"},{"payer":"Kite Pharma, Inc.","program_year":2025,"amount_usd":8682.38,"payment_count":10,"source_url":"https://openpaymentsdata.cms.gov/search?query=1215997085"},{"payer":"Celgene Corporation","program_year":2025,"amount_usd":156.15,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1215997085"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1215997085","source":"payments"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial","year":2021,"journal":"The Lancet Oncology","source_url":"https://doi.org/10.1016/s1470-2045(21)00591-x","status":"verified"},{"title":"KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma","year":2020,"journal":"New England Journal of Medicine","source_url":"https://doi.org/10.1056/nejmoa1914347","status":"verified"},{"title":"Primary Analysis of Zuma-5: A Phase 2 Study of Axicabtagene Ciloleucel (Axi-Cel) in Patients with Relapsed/Refractory (R/R) Indolent Non-Hodgkin Lymphoma (iNHL)","year":2020,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2020-136834","status":"verified"},{"title":"Interim analysis of ZUMA-5: A phase II study of axicabtagene ciloleucel (axi-cel) in patients (pts) with relapsed/refractory indolent non-Hodgkin lymphoma (R/R iNHL).","year":2020,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2020.38.15_suppl.8008","status":"verified"},{"title":"Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial","year":2019,"journal":"The Lancet Haematology","source_url":"https://doi.org/10.1016/s2352-3026(19)30109-7","status":"verified"}],"source":"works"},"contact":{"address_1":"333 COTTMAN AVE","city":"Philadelphia","state":"PA","zip":"191112434","phone":"215-728-6900","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1215997085","source":"identity"},"similar":[{"name":"Elizabeth Plimack","slug":"elizabeth-plimack","institution":"Fox Chase Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/elizabeth-plimack","json_url":"https://www.findmykol.com/kol/elizabeth-plimack/profile.json"},{"name":"Martin Edelman","slug":"martin-edelman","institution":"Fox Chase Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/martin-edelman","json_url":"https://www.findmykol.com/kol/martin-edelman/profile.json"},{"name":"Shazia Nakhoda","slug":"shazia-nakhoda","institution":"Fox Chase Cancer Center","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/shazia-nakhoda","json_url":"https://www.findmykol.com/kol/shazia-nakhoda/profile.json"},{"name":"Hossein Borghaei","slug":"hossein-borghaei","institution":"Fox Chase Cancer Center","specialty":"Magnetic Resonance Imaging (MRI)","url":"https://www.findmykol.com/kol/hossein-borghaei","json_url":"https://www.findmykol.com/kol/hossein-borghaei/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":31,"publications":45}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2013-12-20","collected_at":"2026-11-02T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}